Business
WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING
WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING Canada...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW/\n \n \n \n \n \n CALGARY, AB\n \n \n ,\n \n \n Sept. 12, 2023\n \n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \" or the \"\n \n Company\n \n \") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, is pleased to announce an offering of convertible debenture units of the Company (the \"\n \n Debenture Units\n \n \"), on a non-brokered private placement basis, for aggregate proceeds of up to\n \n C$1\n \n .2 million (the \"\n \n Offering\n \n \"). This offering is being led by insiders including members of the Board of Directors and members of the senior management team of the Company, who are expected to subscribe to approximately 50% of the total funds raised. The Offering is currently open only to accredited investors.\n \n \n Each Debenture Unit will consist of one 12% unsecured convertible debenture in the principal amount of\n \n C$1,000\n \n (each, a \"\n \n Convertible Debenture\n \n \") with a maturity date of 36 months after the closing of the financing (the \"\n \n Maturity Date\n \n \") and 4,762 common share purchase warrants (each, a \"\n \n Warrant\n \n \"). Each Warrant will entitle the holder thereof to purchase one common share of the Company (each a \"\n \n Share\n \n \") at a price of\n \n C$0.105\n \n per Share for a period of 24 months; provided that if, at any time prior to the expiry date of the Warrants, the 20-day volume weighted average of actual closing prices of the Shares on the Toronto Stock Exchange (the \"\n \n TSX\n \n \"), or other principal exchange on which the Shares are liste...